The reduction in percent cell viability examined using the MTT assay was verified, via flow cytometry (annexin V/PI staining), to be mainly caused by the induction of cancer cell death through the apoptotic pathway where RES clearly enhanced cisplatin-induced apoptotic cell death, since our analysis revealed significant synergism of cisplatin–RES treatment. Here, ANXA5 is linked to cancer.